中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease

文献类型:期刊论文

作者Nie Qin2; Du Xiaoguang1; Geng Meiyu2
刊名中国药理学报:英文版
出版日期2011
卷号32.0期号:005页码:545
关键词阿尔茨海默氏病 淀粉样蛋白 小分子 抑制剂 治疗 合作 病理过程
ISSN号1671-4083
英文摘要Amyloid β (Aβ) peptides have long been viewed as a potential target for Alzheimer's disease (AD). Aggregation of Aβ peptides in the brain tissue is believed to be an exclusively pathological process. Therefore, blocking the initial stages of Aβ peptide aggregation with small molecules could hold considerable promise as the starting point for the development of new therapies for AD. Recent rapid progresses in our understanding of toxic amyloid assembly provide a fresh impetus for this interesting approach. Here, we discuss the problems, challenges and new concepts in targeting Aβ peptides.
语种英语
源URL[http://119.78.100.183/handle/2S10ELR8/294962]  
专题中国科学院上海药物研究所
作者单位1.中国科学院上海药物研究所
2.中国海洋大学
推荐引用方式
GB/T 7714
Nie Qin,Du Xiaoguang,Geng Meiyu. Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease[J]. 中国药理学报:英文版,2011,32.0(005):545.
APA Nie Qin,Du Xiaoguang,&Geng Meiyu.(2011).Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.中国药理学报:英文版,32.0(005),545.
MLA Nie Qin,et al."Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease".中国药理学报:英文版 32.0.005(2011):545.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。